Barroso-Sousa, R.; Tyekucheva, S.; Exman, P.; Umeton, R.; Hodi, F. S.; Winer, E. P.; Lin, N. U.; Tolaney, S. M. TUMOR MUTATIONAL BURDEN (TMB) IS A POTENTIAL PREDICTOR OF RESPONSE TO IMMUNE CHECKPOINT INHIBITORS (ICI) IN METASTATIC TRIPLE-NEGATIVE BREAST CANCER (MTNBC). MAST 2019, 29, 5.